Clinical Trial

Sonlicromanol in Post-COVID

Name: Sonlicromanol in Post-COVID — clinical trial record (NCT07298005)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SON4PEM

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The aim of this randomized, double-blind, placebo-controlled, phase II trial, is to study the effect of sonlicromanol on fatigue in patients with post-COVID who experience post-exertional malaise (PEM).

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-14

Trial Details

NCT Number	NCT07298005
Lead Sponsor	Michele van Vugt Collaborators: ZonMw: The Netherlands Organisation for Health Research and Development, Khondrion BV
Conditions	Post COVID Condition
Enrollment	80 participants
Start Date	2026-04
Primary Completion	2027-02 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-04-13